About Eleusis
Eleusis is a company based in London (United Kingdom) founded in 2013 by Charles D. Nichols was acquired by Beckley Psytech in October 2022.. Eleusis has raised $1.47 million across 3 funding rounds from investors including Beckley Psytech. The company has 1 employees as of January 31, 2020. Eleusis has completed 1 acquisition, including Kalypso. Eleusis operates in a competitive market with competitors including ATAI, Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics and Alpine Immune Sciences, among others.
- Headquarter London, United Kingdom
- Employees 1 as on 31 Jan, 2020
- Founders Charles D. Nichols
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Eleusis Holdings Limited
- Date of Incorporation 08 Jun, 2017
- Jurisdiction PIMLICO, LONDON, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.47 M (USD)
in 3 rounds
-
Latest Funding Round
$465 K (USD), Seed
Mar 04, 2022
- Investors
-
Employee Count
1
as on Jan 31, 2020
- Investments & Acquisitions
-
Acquired by
Beckley Psytech
(Oct 24, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Eleusis
Eleusis has successfully raised a total of $1.47M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $465 thousand completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $465,000
-
First Round
First Round
(07 Feb 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Seed - Eleusis | Valuation |
investors |
|
| May, 2016 | Amount | Seed - Eleusis | Valuation |
investors |
|
| Feb, 2014 | Amount | Seed - Eleusis | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eleusis
Eleusis has secured backing from 1 investor. Prominent investors backing the company include Beckley Psytech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of drugs for the treatment of neurological and psychiatric disorders
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eleusis
Eleusis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Kalypso. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Chain of wellness centers
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Eleusis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eleusis Comparisons
Competitors of Eleusis
Eleusis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ATAI, Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics and Alpine Immune Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
|
| domain | founded_year | HQ Location |
Therapies for mental disorders, including psilocybin for depression, are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eleusis
Frequently Asked Questions about Eleusis
When was Eleusis founded?
Eleusis was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Eleusis located?
Eleusis is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Eleusis a funded company?
Eleusis is a funded company, having raised a total of $1.47M across 3 funding rounds to date. The company's 1st funding round was a Seed of $30K, raised on Feb 07, 2014.
How many employees does Eleusis have?
As of Jan 31, 2020, the latest employee count at Eleusis is 1.
What does Eleusis do?
Eleusis was founded in 2013 in London, United Kingdom, as a developer of medicines targeting immunomodulation and neuroprotection. A portfolio of drug candidates has been established to address unmet medical needs in psychiatry and other areas. The lead program, ELE-Psilo, is focused on depression treatment. Operations center on advancing these candidates through clinical development in the biotechnology sector.
Who are the top competitors of Eleusis?
Eleusis's top competitors include Escient Pharmaceuticals, Nimbus Therapeutics and Alpine Immune Sciences.
How many acquisitions has Eleusis made?
Eleusis has made 1 acquisition, including Kalypso.
Who are Eleusis's investors?
Eleusis has 1 investor. Key investors include Beckley Psytech.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.